INTERPACE BIOSCIENCES, INC.
INTERPACE BIOSCIENCES, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 5 | 5 | |||||
Accounts Receivable Net Current | 6 | 6 | 6 | 7 | 9 | 9 | 7 | 6 | 5 | 5 | 5 | 6 | |||||
Other Assets Current | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Assets Current | 10 | 10 | 9 | 10 | 12 | 12 | 9 | 10 | 9 | 10 | 11 | 13 | |||||
Property Plant And Equipment Net | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Deferred Income Tax Assets Net | 21 | 21 | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 33 | 34 | 12 | 12 | 14 | 15 | 14 | 13 | 12 | 13 | 14 | 16 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | |||||
Employee Related Liabilities Current | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | |||||
Other Accrued Liabilities Current | 2 | 2 | 1 | 1 | 2 | 2 | 9 | 9 | 9 | 2 | 9 | 8 | |||||
Lines Of Credit Current | - | - | - | - | - | - | - | - | - | - | - | 2 | |||||
Notes Payable Current | - | - | 1 | 2 | 3 | 4 | 6 | 7 | 7 | 5 | - | - | |||||
Liabilities Of Disposal Group Including Discontinu… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 4 | 5 | 6 | 7 | 9 | 11 | 6 | 7 | 19 | 11 | 12 | 14 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | 1 | 4 | 12 | 11 | |||||
Other Liabilities Noncurrent | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Liabilities | 10 | 11 | 12 | 14 | 15 | 17 | 25 | 25 | 27 | 22 | 30 | 32 | |||||
Stockholders Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | 47 | 47 | 47 | 47 | 47 | 47 | |||||
Common Stock Value | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 235 | 235 | 235 | 235 | 235 | 235 | 188 | 188 | 188 | 188 | 188 | 188 | |||||
Retained Earnings Accumulated Deficit | -210 | -211 | -233 | -234 | -234 | -235 | -244 | -246 | -248 | -242 | -249 | -248 | |||||
Treasury Stock Value | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |||||
Stockholders Equity | 23 | 22 | -0 | -1 | -1 | -2 | -51 | -52 | -55 | -56 | -63 | -62 | |||||
Liabilities And Stockholders Equity | 33 | 34 | 12 | 12 | 14 | 15 | 14 | 13 | 12 | 13 | 14 | 16 | |||||
Allowance For Doubtful Accounts Receivable | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | 0 | 0 | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | |||||
Common Stock Shares Issued | 223 | 228 | 228 | 228 | 228 | 227 | 227 | 224 | 224 | 222 | 220 | 220 | |||||
Shares Outstanding | 222 | 221 | 221 | 221 | 221 | 220 | 220 | 219 | 219 | 218 | 216 | 216 | |||||
Treasury Stock Common Shares | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -16.50% | -18.50% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 20.93% | 15.66% | 39.53% | -1.54% | 4.96% | 9.93% | 6.80% | 19.00% | 89.00% | 18.98% | 9.64% | 0.42% |
| 2024 | - | - | - | 5.45% | 22.33% | 97.82% | -5.20% | -18.96% | -73.09% | -30.85% | -6.91% | -18.09% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.51 | 1.94 | 1.54 | 1.33 | 1.34 | 1.11 | 1.54 | 1.34 | 0.50 | 0.91 | 0.93 | 0.96 | |||||
| Quick Ratio | 2.51 | 1.94 | 1.54 | 1.33 | 1.34 | 1.11 | 1.54 | 1.34 | 0.50 | 0.91 | 0.93 | 0.96 | |||||
| Working Capital | 6.00M | 4.80M | 3.19M | 2.36M | 2.98M | 1.16M | 3.20M | 2.40M | -9.56M | -1.02M | -886.00K | -590.00K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.45 | 0.51 | -41.39 | -11.17 | -25.90 | -7.67 | -0.50 | -0.49 | -0.49 | -0.40 | -0.48 | -0.51 | |||||
| Interest Coverage TTM | 37.53 | 24.31 | 17.04 | 15.10 | 17.44 | 12.97 | 11.71 | 7.59 | 5.06 | 4.42 | 2.15 | 1.48 | |||||
| Debt Ratio | 0.31 | 0.34 | 1.02 | 1.10 | 1.04 | 1.15 | 1.79 | 1.96 | 2.20 | 1.69 | 2.13 | 1.98 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.51 | 1.59 | 3.21 | 3.59 | 3.62 | 3.36 | 3.15 | 2.86 | 2.88 | 2.75 | 2.59 | 1.45 | |||||
| Days Sales Outstanding TTM | 73.98 | 66.88 | 57.73 | 53.95 | 52.08 | 52.98 | 49.58 | 51.73 | 43.93 | 46.09 | 45.90 | 58.48 | |||||
| Receivables Turnover TTM | 4.93 | 5.46 | 6.32 | 6.77 | 7.01 | 6.89 | 7.36 | 7.06 | 8.31 | 7.92 | 7.95 | 6.24 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.85 | 0.89 | 0.14 | 0.17 | 0.28 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | |||||
| Free Cash Flow Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 62.53% | 62.31% | 62.01% | 62.60% | 64.20% | 63.77% | 65.68% | 63.67% | 62.86% | 62.58% | 59.53% | 60.36% | |||||
| Operating Profit Margin TTM | 9.32% | 10.55% | 10.90% | 12.59% | 18.28% | 17.28% | 19.08% | 14.96% | 10.88% | 9.88% | 4.04% | 2.09% | |||||
| Net Profit Margin TTM | 65.25% | 63.46% | 9.06% | 10.04% | 15.83% | 14.28% | 15.38% | 11.04% | 5.72% | 4.88% | -4.32% | -40.80% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -24.90% | -17.47% | -6.07% | 9.78% | 19.50% | 17.21% | 16.62% | 10.79% | 19.70% | 25.75% | 38.73% | 36.16% | |||||
| Net Income Growth (1Y) | 209.50% | 266.68% | -44.65% | -0.20% | 230.64% | 242.99% | -515.44% | -129.99% | -111.94% | -108.90% | -93.15% | 13.13% | |||||
| EPS Growth (1Y) | 200.18% | 263.61% | -45.05% | -1.26% | 226.90% | 237.52% | -508.44% | -129.55% | -111.76% | -108.74% | -93.27% | 10.98% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 1,821.03 | 1,107.13 | 5,241.51 | 3,634.15 | 2,718.75 | 8,830.29 | 5,760.89 | - | - | - | - | - | |||||
| P/B TTM | 1,865.76 | 1,216.63 | -66,820.47 | -13,673.74 | -35,694.16 | -26,694.01 | -782.32 | - | - | - | - | - | |||||
| P/S TTM | 1,188.18 | 702.53 | 475.08 | 364.91 | 430.43 | 1,261.15 | 886.06 | - | - | - | - | - | |||||
| Market Cap | 43.07B | 27.21B | 19.91B | 16.59B | 20.77B | 59.18B | 39.54B | - | - | - | - | - | |||||
| Enterprise Value | 43.06B | 27.21B | 19.91B | 16.59B | 20.78B | 59.18B | 39.54B | - | - | - | - | - | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 4.38M | 5.48M | 4.43M | 4.20M | 5.09M | 3.77M | 3.71M | 3.07M | 2.17M | 3.32M | 1.85M | -2.39M | |||||
| Net Debt | -2.65M | 616.00K | -446.00K | 1.27M | 1.57M | 2.83M | 3.58M | 4.77M | 6.03M | 5.85M | 6.53M | 7.73M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
INTERPACE BIOSCIENCES, INC. (IDXG) — SEC Financial Statements & Analysis
INTERPACE BIOSCIENCES, INC. (IDXG) is a surgical & medical instruments & apparatus company, incorporated in DE. INTERPACE BIOSCIENCES, INC. trades on IDXG: OTC as: IDXG. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), INTERPACE BIOSCIENCES, INC. reported a -24.90% year-over-year revenue growth, a Gross Profit Margin of 62.53% (TTM), a Debt-to-Equity ratio of 0.45x, a Price-to-Sales (P/S) ratio of 1188.18x (TTM), a Price-to-Book (P/B) ratio of 1.87K (TTM), at a market cap of $43.07B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -24.90%
- Gross Profit Margin TTM
- 62.53%
- Debt To Equity
- 0.45x
- P/S TTM
- 1188.18x
- P/B TTM
- 1.87K
- Market Cap
- $43.07B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTERPACE BIOSCIENCES, INC. in?
INTERPACE BIOSCIENCES, INC. (IDXG) operates in the Surgical & Medical Instruments & Apparatus industry.
What is IDXG's market cap?
INTERPACE BIOSCIENCES, INC. (IDXG) has a market capitalization of $43.07B as of 2026-03-31.
What is IDXG's P/E ratio?
INTERPACE BIOSCIENCES, INC. (IDXG)'s trailing twelve month P/E ratio is 1821.03x as of 2026-03-31.
What exchange does IDXG trade on?
INTERPACE BIOSCIENCES, INC. (IDXG) trades on the IDXG: OTC.
Where is INTERPACE BIOSCIENCES, INC. incorporated?
INTERPACE BIOSCIENCES, INC. is incorporated in DE.